394 High-affinity PRAME TCRs synergize with tailored CD8 co-receptor and switch receptors to generate potential best-in-class PRAME-targeting TCR-T therapy

• Elisa Kieback,
• Mikhail Steklov,
• Lucia Poncette,
• Lia Walcher,
• Lorenz Knackstedt,
• Friederike Knipping,
• Paul Najm,
• Paul Zschimmer,
• Panagiota A Sotiropoulou,
• Marleen van Loenen

Affiliations

Elisa Kieback

1T-knife Therapeutics Inc., San Francisco, CA, USA

Mikhail Steklov

1T-knife Therapeutics Inc., San Francisco, CA, USA

Lucia Poncette

1T-knife Therapeutics Inc., San Francisco, CA, USA

Lia Walcher

1T-knife Therapeutics Inc., San Francisco, CA, USA

Lorenz Knackstedt

1T-knife Therapeutics Inc., San Francisco, CA, USA

Friederike Knipping

1T-knife Therapeutics Inc., San Francisco, CA, USA

Paul Najm

2T-knife Therapeutics Inc., Berlin, Germany

Paul Zschimmer

1T-knife Therapeutics Inc., San Francisco, CA, USA

Panagiota A Sotiropoulou

1T-knife Therapeutics Inc., San Francisco, CA, USA

Marleen van Loenen

1T-knife Therapeutics Inc., San Francisco, CA, USA